Objective: To analyze the use of medicines and the main therapeutic groups consumed by persons with physical, hearing and visual disabilities.
Methods: A cross-sectional study was performed, where data from the 2002 Inquérito Multicêntrico de Saúde no Estado de São Paulo (ISA-SP - São Paulo State Multicenter Health Survey), as well as the 2003 Inquérito de Saúde no Município de São Paulo (ISA-Capital - City of São Paulo Health Survey), Southeastern Brazil, were analyzed. Respondents who reported having disabilities were studied, according to variables that comprise the database: geographic area, gender, income, age group, ethnic group, use of medicines and types of drugs consumed.
Results: The percentage of use of drugs by persons with disabilities was 62.8% among the visually impaired; 60.2% among the hearing impaired; and 70.1% among the persons with physical disabilities. Individuals with physical disabilities consumed 20% more medications than non-disabled ones. Among persons with visual disabilities, the most frequently consumed drugs were diuretics, agents of the renin-angiotensin system and analgesics. Persons with hearing disabilities used more analgesics and agents of the renin-angiotensin system. Among those with physical disabilities, analgesics, antithrombotics and agents of the renin-angiotensin system were the most frequently consumed medicines.
Conclusions: There was a greater use of medicines among persons with disabilities than non-disabled ones. Persons with physical disabilities were those who most consumed medicines, followed by the visually impaired and the hearing impaired.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1590/s0034-89102010000400003 | DOI Listing |
J Surg Oncol
October 2024
Liver Surgery Unit, Department of Gastroenterology, Digestive Surgery Division, University of Saão Paulo Medical School, São Paulo, Brazil.
J Funct Biomater
March 2024
Bone Research Lab, Ribeiraão Preto School of Dentistry, University of Saão Paulo, Ribeiraão Preto 14040-904, SP, Brazil.
Bone tissue has a remarkable ability to regenerate following injury and trauma [...
View Article and Find Full Text PDFArq Bras Cardiol
March 2024
Universidade Federal do Vale do Saão Francisco - Colegiado de Medicina, Paulo Afonso, BA - Brasil.
Front Immunol
November 2023
Hospital Israelita Albert Einstein, São Paulo, Brazil.
Background: The frequency of antibodies in autoimmune encephalitis (AIE) may vary in different populations, however, data from developing countries are lacking. To describe the clinical profile of AIE in Brazil, and to evaluate seasonality and predictors of AIE in adult and pediatric patients.
Methods: We evaluated patients with possible AIE from 17 centers of the Brazilian Autoimmune Encephalitis Network (BrAIN) between 2018 and 2022.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!